Saxenda in Obesity Services (STRIVE Study)

Summary

Saxenda in Obesity Services (STRIVE Study) is a clinical trial^[1].

Key Facts

• Saxenda in Obesity Services (STRIVE Study) is in the country of Ireland^[2].
• Saxenda in Obesity Services (STRIVE Study) is in the country of United Kingdom^[3].
• Saxenda in Obesity Services (STRIVE Study)'s instance of is recorded as clinical trial^[4].
• Saxenda in Obesity Services (STRIVE Study)'s start time is recorded as +2017-11-28T00:00:00Z^[5].
• Saxenda in Obesity Services (STRIVE Study)'s end time is recorded as +2020-09-30T00:00:00Z^[6].
• Saxenda in Obesity Services (STRIVE Study)'s main subject is recorded as diabetes^[7].
• Saxenda in Obesity Services (STRIVE Study)'s main subject is recorded as obesity^[8].
• Saxenda in Obesity Services (STRIVE Study)'s number of participants is recorded as {'unit': '1', 'amount': '+375'}^[9].
• Saxenda in Obesity Services (STRIVE Study)'s title is recorded as EFFECTIVENESS AND COST OF INTEGRATING A PROTOCOL WITH USE OF LIRAGLUTIDE 3.0 MG INTO AN OBESITY SERVICE: (STRIVE Study)^[10].
• Saxenda in Obesity Services (STRIVE Study)'s short name is recorded as STRIVE^[11].
• Saxenda in Obesity Services (STRIVE Study)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Saxenda in Obesity Services (STRIVE Study)'s ClinicalTrials.gov ID is recorded as NCT03036800^[13].
• Saxenda in Obesity Services (STRIVE Study)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[14].
• Saxenda in Obesity Services (STRIVE Study)'s research intervention is recorded as liraglutide^[15].
• Saxenda in Obesity Services (STRIVE Study)'s clinical trial phase is recorded as phase IV clinical trial^[16].
• Saxenda in Obesity Services (STRIVE Study)'s research site is recorded as University of Liverpool^[17].
• Saxenda in Obesity Services (STRIVE Study)'s study type is recorded as interventional study^[18].